Co-Diagnostics Inc (CODX)
1.28
+0.08
(+6.67%)
USD |
NASDAQ |
Oct 04, 16:00
1.25
-0.03
(-2.34%)
After-Hours: 20:00
Co-Diagnostics Shareholders Equity (Annual): 86.01M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 86.01M |
| December 31, 2022 | 114.52M |
| December 31, 2021 | 134.48M |
| December 31, 2020 | 66.70M |
| December 31, 2019 | 1.737M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.059M |
| December 31, 2017 | 3.850M |
| December 31, 2016 | -2.995M |
| December 31, 2015 | -1.147M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
1.737M
Minimum
2019
134.48M
Maximum
2021
80.69M
Average
86.01M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Abbott Laboratories | 38.60B |
| Emergent BioSolutions Inc | 649.30M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| SIGA Technologies Inc | 196.86M |
| Chimerix Inc | 193.03M |